These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 17239261)
61. The modern histopathologist: in the changing face of time. Saikia B; Gupta K; Saikia UN Diagn Pathol; 2008 Jun; 3():25. PubMed ID: 18534037 [TBL] [Abstract][Full Text] [Related]
62. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260 [TBL] [Abstract][Full Text] [Related]
63. Population-based molecular prognosis of breast cancer by transcriptional profiling. Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081 [TBL] [Abstract][Full Text] [Related]
64. A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202 [TBL] [Abstract][Full Text] [Related]
65. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737 [TBL] [Abstract][Full Text] [Related]
66. Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. Lyman GH; Kuderer NM Clin Breast Cancer; 2006 Dec; 7(5):372-9. PubMed ID: 17239261 [TBL] [Abstract][Full Text] [Related]
67. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Ross JS Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609 [TBL] [Abstract][Full Text] [Related]
68. Gene expression profiling: decoding breast cancer. de Snoo F; Bender R; Glas A; Rutgers E Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448 [TBL] [Abstract][Full Text] [Related]
69. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
70. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. Albain KS; Paik S; van't Veer L Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534 [TBL] [Abstract][Full Text] [Related]
71. Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. Kuderer NM; Lyman GH Cancer Invest; 2009 Nov; 27(9):885-90. PubMed ID: 19832034 [No Abstract] [Full Text] [Related]
72. Systematic review: gene expression profiling assays in early-stage breast cancer. Marchionni L; Wilson RF; Wolff AC; Marinopoulos S; Parmigiani G; Bass EB; Goodman SN Ann Intern Med; 2008 Mar; 148(5):358-69. PubMed ID: 18252678 [TBL] [Abstract][Full Text] [Related]
73. Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer. Tordai A; Liedtke C; Pusztai L Clin Exp Metastasis; 2009; 26(7):625-32. PubMed ID: 19381845 [TBL] [Abstract][Full Text] [Related]